Former Myriad CSO and genetics trailblazer Dr. Jerry Lanchbury joins Kian to chart the field’s evolution—from manual lab work and the first PCR runs to today’s embryo ranking software and whole‑genome newborn programs. Along the way, we unpack gene‑patent battles, polygenic risk scores, and the growing role patients play in steering reproductive medicine.